Answers are grounded in this paper and cite their sources.
A 31-year-old male of African origin with Fitzpatrick skin type VI presented with itchy, dry skin on his face and limbs. Past medical history included childhood eczema, deep vein thrombosis and sickle cell trait. He worked in social care. On examination, numerous 2–3 mm pits were identified along both palmar creases (Figures 1 and 2). His feet were unaffected. The lesions had been present for years and were asymptomatic. The clinical findings were consistent with a diagnosis of keratosis punctata of the palmar creases (KPPC). KPPC is a benign hyperkeratotic dermatosis.1 Its aetiology is unknown, but as lesions occur at the sites of acrosyringia, it has been theorized that it may result from sweat gland pathology.2 It has an estimated prevalence of 1.5–3% among African males, may be associated with friction, and is thought to be autosomal dominant.1, 3 Typically, lesions develop during puberty, forming hyperkeratotic plugs which eventually break off, resulting in residual chronic pits.1 Histological findings include hyperkeratotic plugs depressing the epidermis.1 Feet are rarely affected. It is distinct from other palmar pit conditions, being located exclusively in the palmar creases, differentiating it from verrucae vulgaris, spiny keratoderma, palmoplantar keratoderma, arsenical keratosis and syphilitic keratosis.3 We report this benign infrequent indolent condition, with no significant sequelae. Paula Finnegan: lead in concept & design, patient communication, and initial draft; support in final draft; equal contribution to final approval. Oonagh Molloy: supervisor in concept & design, patient communication and initial draft; lead in final draft; equal contribution to final approval. The authors declare no conflict of interest. None All patients in this manuscript have given written informed consent for participation in the study and the use of their de-identified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical Approval: not applicable.
No takes yet. Share an insight, caveat, or question.
Finnegan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: